Benchmark Downgrades Beauty Health to Hold
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bruce Jackson has downgraded Beauty Health (NASDAQ:SKIN) from Buy to Hold, indicating a change in the stock's outlook.
November 14, 2023 | 12:48 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Beauty Health was downgraded by Benchmark analyst Bruce Jackson from Buy to Hold, which may influence investor sentiment and the stock's performance.
Analyst ratings often impact stock prices as they reflect changes in the market's view on the company's future performance. A downgrade from Buy to Hold suggests a less optimistic outlook, which could lead to a decrease in investor confidence and a potential short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100